display:none
Skip to main content

DiMe Publications

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency

This FDA guidance provides general considerations to assurance the safety of trial participants, maintaining compliance with good clinical practice, and minimizing risks to trial integrity during COVID-19.

April 21st, 2020

View DiMe Comment

Read Full Article
Return to Publications
Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today